LTP 0.79% $1.25 ltr pharma limited

Revenue - what does it look like?, page-54

  1. 2,806 Posts.
    lightbulb Created with Sketch. 2503
    That's fascinating, if they can apply the technology to multiple different conditions then the potential here goes up by that multiple.

    This could do $500M USD pa in sales (and foreseeably do over $1Bn) for Spontan alone; a revenue multiple of 3-5 gives $1.5-2.5Bn USD for ED alone. Call that $2Bn USD.

    Add 4 new conditions and potentially we multiply the valuation by 5! Then there will be more conditions down the track you would imagine ...

    That's a starting point of about 20 times our market cap, with the potential to multiply from there.

    I'm not predicting share prices here, just trying to layout thinking on potential value. Looks good IMHO
 
watchlist Created with Sketch. Add LTP (ASX) to my watchlist
(20min delay)
Last
$1.25
Change
-0.010(0.79%)
Mkt cap ! $105.9M
Open High Low Value Volume
$1.26 $1.33 $1.23 $617.7K 487.4K

Buyers (Bids)

No. Vol. Price($)
3 11277 $1.25
 

Sellers (Offers)

Price($) Vol. No.
$1.28 1327 1
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
LTP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.